glp-1 kidney outcomes news Updated evidence on cardiovascular and renal effects of receptor agonists and combination therapy with SGLT2 inhibitors and finerenone: a narrative review and perspectives | Cardiovascular Diabetology glp-1 cardiovascular outcomes news receptor

Mechanism of Action in Weight Loss GLP-1 receptor agonists work primarily by reducing appetite and increasing satiety

These compounds enhance the liver and gallbladder's role by decreasing fat deposits and speeding up metabolism of fat and its removal

Although GLP-1 can inhibit gastric emptying thereby reducing pancreatic stimulation, in follow-up studies, GLP-1 was shown to inhibit pancreatic digestive enzyme secretion stimulated by carbachol infusion (43)

L-carnitine accomplishes this by binding to acyl residues produced not only from fatty acids but also from amino acid metabolism, forming water-soluble acylcarnitines that facilitate their excretion from cells and ultimately the body (Figure 1) (19, 20)

Lebon, T